City

Dallas (1)

Condition

Hematologic Tumors (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

ChemGenex Pharmaceuticals (1)

Collaborator

Intervention

omacetaxine (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

hematologic tumors

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hematologic Tumors Trial in Dallas (Omacetaxine)

Completed

Hematologic Tumors

Omacetaxine

Dallas, Texas

Mary Crowley Cancer Research Center

May 9, 2014